IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $521,320 | -89.3% | 47,221 | -81.5% | 0.00% | -86.2% |
| Q4 2021 | $4,878,564 | -78.1% | 255,556 | -70.1% | 0.03% | -79.3% |
| Q2 2021 | $22,266,875 | +207.7% | 855,760 | +274.3% | 0.14% | +122.2% |
| Q1 2021 | $7,237,476 | -85.5% | 228,600 | -78.7% | 0.06% | -83.9% |
| Q4 2020 | $49,912,480 | +2943.4% | 1,075,700 | +1700.1% | 0.39% | +1963.2% |
| Q2 2020 | $1,640,000 | -90.7% | 59,757 | -89.9% | 0.02% | -90.3% |
| Q1 2020 | $17,633,000 | +809.9% | 589,028 | +741.5% | 0.20% | +1200.0% |
| Q4 2019 | $1,938,000 | -17.8% | 70,000 | -46.0% | 0.02% | -16.7% |
| Q3 2019 | $2,357,000 | +92.3% | 129,535 | +159.1% | 0.02% | +100.0% |
| Q2 2019 | $1,226,000 | +68.6% | 50,000 | +16.3% | 0.01% | +125.0% |
| Q1 2018 | $727,000 | – | 43,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |